LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

Search

Quidel Corp

Fermé

17.66 2.97

Résumé

Variation du prix de l'action

24h

Actuel

Min

17.1

Max

17.66

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+79.82% upside

Dividendes

By Dow Jones

Prochains Résultats

6 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-54M

1.2B

Ouverture précédente

14.69

Clôture précédente

17.66

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

16 mars 2026, 21:37 UTC

Acquisitions, Fusions, Rachats

Lensar and Alcon Agree to Terminate Merger

16 mars 2026, 19:06 UTC

Principaux Événements d'Actualité

Mideast Loses 12 Million Boe/d Following Hormuz Closure: Rystad -- OPIS

16 mars 2026, 17:44 UTC

Acquisitions, Fusions, Rachats

Novartis Issues Debt Offering to Help Fund $12 Billion Acquisition of Avidity Biosciences

16 mars 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 mars 2026, 23:46 UTC

Market Talk

Nikkei May Rise After Oil Prices Decline -- Market Talk

16 mars 2026, 23:37 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

16 mars 2026, 23:05 UTC

Market Talk

Slumping Consumer Confidence Highlights Risk Around RBA Hike -- Market Talk

16 mars 2026, 21:56 UTC

Market Talk

DUG Technology's Stock Fall Creates Opportunity -- Market Talk

16 mars 2026, 21:41 UTC

Market Talk
Principaux Événements d'Actualité

Global Equities Roundup: Market Talk

16 mars 2026, 21:41 UTC

Market Talk
Principaux Événements d'Actualité

Clouds Gather Over Auckland Intl Airport as Airlines Up Fares -- Market Talk

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 mars 2026, 20:57 UTC

Acquisitions, Fusions, Rachats

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

16 mars 2026, 20:51 UTC

Acquisitions, Fusions, Rachats

Nvidia-Backed Nscale Plans Huge Data Center Cluster in West Virginia -- WSJ

16 mars 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

16 mars 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Energy & Utilities Roundup: Market Talk

16 mars 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 mars 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

16 mars 2026, 19:53 UTC

Principaux Événements d'Actualité

U.S. Allies Rebuff Trump's Demand for Help Opening Strait of Hormuz -- WSJ

16 mars 2026, 19:43 UTC

Market Talk

Global Equities Roundup: Market Talk

16 mars 2026, 19:43 UTC

Market Talk

Nvidia Sees $1 Trillion in Blackwell, Rubin Orders Through 2027 -- Market Talk

16 mars 2026, 19:37 UTC

Market Talk
Principaux Événements d'Actualité

Natural Gas Follows Oil Prices Lower -- Market Talk

16 mars 2026, 19:20 UTC

Principaux Événements d'Actualité

Stock Market Today: Dow Jumps, Brent Crude Pulls Back From $105 -- WSJ

16 mars 2026, 19:17 UTC

Market Talk
Principaux Événements d'Actualité

Crude Oil Sinks on Signals from Strait of Hormuz -- Market Talk

16 mars 2026, 19:00 UTC

Market Talk

Bank of Canada Needs Dovish Approach Based on Weak Data -- Market Talk

16 mars 2026, 18:23 UTC

Market Talk

LME Restarts Trading After Outage -- Market Talk

16 mars 2026, 17:36 UTC

Principaux Événements d'Actualité

Oil Prices Fall as Trump Says Hormuz Help Is Coming. Tankers Getting Through, Bessent Adds. -- Barrons.com

16 mars 2026, 17:19 UTC

Market Talk

Grains Sink as Investors Steer Toward Equities -- Market Talk

16 mars 2026, 17:14 UTC

Principaux Événements d'Actualité

Trump Ends News Conference

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

79.82% hausse

Prévisions sur 12 Mois

Moyen 30.75 USD  79.82%

Haut 38 USD

Bas 25 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat